Binding of KDR peptides and controls to human HLA-A*0201
Name . | Position . | 1 2 3 4 5 6 7 8 9 10 . | Score* . | Fluorescence index† . |
---|---|---|---|---|
KDR peptides | ||||
KDR6-15 | 6-15 | L L A V A L W L C V | 25 | 0.87 |
KDR35-43 | 35-43 | S I Q K D I L T I | 25 | 0.77 |
KDR82-90 | 82-90 | G L F C K T L T I | 26 | 0.81 |
KDR153-161 | 153-161 | S I S N L N V S L | 25 | 0.21 |
KDR211-219 | 211-219 | S I M Y I V V V V | 26 | 0.30 |
KDR227-236 | 227-236 | V L S P S H G I E L | 25 | 0.92 |
KDR288-297 | 288-297 | F L S T L T I D G V | 26 | 1.39 |
KDR505-514 | 505-514 | A L I E G K N K T V | 27 | 1.39 |
KDR625-634 | 625-634 | L I M E L K N A S L | 27 | 0.77 |
KDR766-774 | 766-774 | I I L V G T A V I | 26 | 0.82 |
KDR775-783 | 775-783 | A M F F W L L L V | 25 | 0.74 |
KDR781-789 | 781-789 | L L V I I L R T V | 28 | 0.85 |
KDR881-889 | 881-889 | A L M S E L K I L | 26 | 1.01 |
KDR888-896 | 888-896 | I L I H I G H H L | 25 | 0.57 |
KDR1034-1044 | 1035-1044 | L L S E K N V V K I | 30 | 0.87 |
KDR1076-1084 | 1076-1084 | T I F D R V Y T I | 25 | 0.59 |
KDR1093-1101 | 1093-1101 | V L L W E I F S L | 29 | 1.03 |
KDR1263-1272 | 1263-1272 | V L A S E E L K T L | 28 | 1.04 |
KDR1342-1351 | 1342-1351 | I L Q P D S G T T L | 26 | 0.62 |
Control peptides | ||||
Melan-A27-35 | 27-35 | A A G I G I L T V | 25 | 0.84 |
TRP2288-296 | 288-296 | S L D D Y N H L V | 25 | 0.81 |
TYR454-463‡ | 454-463 | D S D P D S F Q D Y | 1 | 0.01 |
Name . | Position . | 1 2 3 4 5 6 7 8 9 10 . | Score* . | Fluorescence index† . |
---|---|---|---|---|
KDR peptides | ||||
KDR6-15 | 6-15 | L L A V A L W L C V | 25 | 0.87 |
KDR35-43 | 35-43 | S I Q K D I L T I | 25 | 0.77 |
KDR82-90 | 82-90 | G L F C K T L T I | 26 | 0.81 |
KDR153-161 | 153-161 | S I S N L N V S L | 25 | 0.21 |
KDR211-219 | 211-219 | S I M Y I V V V V | 26 | 0.30 |
KDR227-236 | 227-236 | V L S P S H G I E L | 25 | 0.92 |
KDR288-297 | 288-297 | F L S T L T I D G V | 26 | 1.39 |
KDR505-514 | 505-514 | A L I E G K N K T V | 27 | 1.39 |
KDR625-634 | 625-634 | L I M E L K N A S L | 27 | 0.77 |
KDR766-774 | 766-774 | I I L V G T A V I | 26 | 0.82 |
KDR775-783 | 775-783 | A M F F W L L L V | 25 | 0.74 |
KDR781-789 | 781-789 | L L V I I L R T V | 28 | 0.85 |
KDR881-889 | 881-889 | A L M S E L K I L | 26 | 1.01 |
KDR888-896 | 888-896 | I L I H I G H H L | 25 | 0.57 |
KDR1034-1044 | 1035-1044 | L L S E K N V V K I | 30 | 0.87 |
KDR1076-1084 | 1076-1084 | T I F D R V Y T I | 25 | 0.59 |
KDR1093-1101 | 1093-1101 | V L L W E I F S L | 29 | 1.03 |
KDR1263-1272 | 1263-1272 | V L A S E E L K T L | 28 | 1.04 |
KDR1342-1351 | 1342-1351 | I L Q P D S G T T L | 26 | 0.62 |
Control peptides | ||||
Melan-A27-35 | 27-35 | A A G I G I L T V | 25 | 0.84 |
TRP2288-296 | 288-296 | S L D D Y N H L V | 25 | 0.81 |
TYR454-463‡ | 454-463 | D S D P D S F Q D Y | 1 | 0.01 |
Algorithmic score of the probability of being processed and presented according to SYFPEITHI software (www.syfpeithi.de)
(Mean fluorescence with peptide–mean fluorescence without peptide)/(mean fluorescence without peptide). Shown are representative results of 2 independent experiments
Peptide sequence derived from tyrosinase, known to bind to HLA-A1 (negative controls)